Momordica charantia silver nanoparticles modulate SOCS/JAK/STAT and P13K/Akt/PTEN signalling pathways in the kidney of streptozotocin-induced diabetic rats.
Olusola Olalekan ElekofehintiVictor Oluwatoyin OyedokunOpeyemi IwaloyeAkeem Olalekan LawalOluwamodupe Cecilia EjelonuPublished in: Journal of diabetes and metabolic disorders (2021)
Observation drawn from this study suggests that M. charantia nanoparticles ameliorate DN through regulation of SOCS/JAK/STAT and PI3K/Akt/PTEN signalling pathways.